Page last updated: 2024-09-02

fingolimod hydrochloride and Hepatoblastoma

fingolimod hydrochloride has been researched along with Hepatoblastoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aye, JM; Beierle, EA; Marayati, R; Mroczek-Musulman, E; Stafman, LL; Stewart, JE; Williams, AP	1

Other Studies

1 other study(ies) available for fingolimod hydrochloride and Hepatoblastoma

Article	Year
PP2A activation alone and in combination with cisplatin decreases cell growth and tumor formation in human HuH6 hepatoblastoma cells. PloS one, 2019, Volume: 14, Issue:4 Topics: Animals; Apoptosis; Autoantigens; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Cisplatin; DNA-Binding Proteins; Female; Fingolimod Hydrochloride; Hepatoblastoma; Histone Chaperones; Humans; Intracellular Signaling Peptides and Proteins; Liver Neoplasms; Membrane Proteins; Mice; Mice, Nude; Neoplasm Transplantation; Protein Phosphatase 2; Transcription Factors	2019

Article

Year

PP2A activation alone and in combination with cisplatin decreases cell growth and tumor formation in human HuH6 hepatoblastoma cells.

PloS one, 2019, Volume: 14, Issue:4

Topics: Animals; Apoptosis; Autoantigens; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Cisplatin; DNA-Binding Proteins; Female; Fingolimod Hydrochloride; Hepatoblastoma; Histone Chaperones; Humans; Intracellular Signaling Peptides and Proteins; Liver Neoplasms; Membrane Proteins; Mice; Mice, Nude; Neoplasm Transplantation; Protein Phosphatase 2; Transcription Factors

2019